Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP434919.RAu1IJmMPJfwJDQ_HjLUayQmgm6OiES0mivvxTT6zgPcQ130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP434919.RAu1IJmMPJfwJDQ_HjLUayQmgm6OiES0mivvxTT6zgPcQ130_assertion type Assertion NP434919.RAu1IJmMPJfwJDQ_HjLUayQmgm6OiES0mivvxTT6zgPcQ130_head.
- NP434919.RAu1IJmMPJfwJDQ_HjLUayQmgm6OiES0mivvxTT6zgPcQ130_assertion description "[Mutations in the gene mitofusin 2 (MFN2) cause the axonal subtype CMT2A, which has also been shown to be associated with optic atrophy, clinical signs of first motor neuron involvement, and early onset stroke.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP434919.RAu1IJmMPJfwJDQ_HjLUayQmgm6OiES0mivvxTT6zgPcQ130_provenance.
- NP434919.RAu1IJmMPJfwJDQ_HjLUayQmgm6OiES0mivvxTT6zgPcQ130_assertion evidence source_evidence_literature NP434919.RAu1IJmMPJfwJDQ_HjLUayQmgm6OiES0mivvxTT6zgPcQ130_provenance.
- NP434919.RAu1IJmMPJfwJDQ_HjLUayQmgm6OiES0mivvxTT6zgPcQ130_assertion SIO_000772 21258814 NP434919.RAu1IJmMPJfwJDQ_HjLUayQmgm6OiES0mivvxTT6zgPcQ130_provenance.
- NP434919.RAu1IJmMPJfwJDQ_HjLUayQmgm6OiES0mivvxTT6zgPcQ130_assertion wasDerivedFrom befree-20140225 NP434919.RAu1IJmMPJfwJDQ_HjLUayQmgm6OiES0mivvxTT6zgPcQ130_provenance.
- NP434919.RAu1IJmMPJfwJDQ_HjLUayQmgm6OiES0mivvxTT6zgPcQ130_assertion wasGeneratedBy ECO_0000203 NP434919.RAu1IJmMPJfwJDQ_HjLUayQmgm6OiES0mivvxTT6zgPcQ130_provenance.